X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21119) 21119
Book Review (3861) 3861
Publication (1523) 1523
Book Chapter (232) 232
Conference Proceeding (178) 178
Dissertation (115) 115
Magazine Article (41) 41
Newsletter (31) 31
Book / eBook (11) 11
Paper (6) 6
Web Resource (5) 5
Journal / eJournal (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15829) 15829
humans (10784) 10784
animals (7613) 7613
glycation end-products (7024) 7024
male (5588) 5588
oxidative stress (4762) 4762
glycation (4079) 4079
female (3866) 3866
diabetes (3826) 3826
glycation end products, advanced - metabolism (3541) 3541
biochemistry & molecular biology (3129) 3129
rats (2895) 2895
middle aged (2804) 2804
proteins (2780) 2780
receptor for advanced glycation end products (2657) 2657
glycosylation (2645) 2645
advanced glycation end products (2544) 2544
mice (2397) 2397
endocrinology & metabolism (2304) 2304
inflammation (2258) 2258
aged (2161) 2161
glucose (2052) 2052
adult (1996) 1996
maillard reaction (1944) 1944
rage (1863) 1863
receptor (1792) 1792
diabetes mellitus (1784) 1784
expression (1680) 1680
complications (1581) 1581
cell biology (1570) 1570
pharmacology & pharmacy (1548) 1548
atherosclerosis (1414) 1414
age (1359) 1359
risk factors (1357) 1357
analysis (1351) 1351
receptors, immunologic - metabolism (1326) 1326
cells, cultured (1324) 1324
research (1264) 1264
in-vitro (1205) 1205
disease (1198) 1198
end-products (1181) 1181
urology & nephrology (1130) 1130
methylglyoxal (1127) 1127
food science & technology (1116) 1116
physiological aspects (1110) 1110
medicine, research & experimental (1108) 1108
activation (1097) 1097
apoptosis (1087) 1087
advanced glycation endproducts (1068) 1068
collagen (1057) 1057
hyperglycemia (1052) 1052
lysine - analogs & derivatives (1029) 1029
protein (1021) 1021
health aspects (1015) 1015
aging (1003) 1003
cells (996) 996
glycation end products, advanced - blood (985) 985
article (954) 954
signal transduction (900) 900
mellitus (874) 874
diabetes-mellitus (869) 869
neurosciences (850) 850
rats, wistar (835) 835
rats, sprague-dawley (832) 832
advanced glycosylation end products (831) 831
abridged index medicus (826) 826
type 2 diabetes (798) 798
antioxidants (795) 795
disease models, animal (790) 790
nonenzymatic glycation (790) 790
biophysics (765) 765
endothelial-cells (763) 763
reactive oxygen species - metabolism (759) 759
diabetic complications (752) 752
oxidation-reduction (744) 744
rodents (738) 738
immunohistochemistry (736) 736
ages (724) 724
pathogenesis (719) 719
immunology (712) 712
dextrose (710) 710
peripheral vascular disease (710) 710
biomarkers - blood (709) 709
cattle (707) 707
aged, 80 and over (696) 696
time factors (696) 696
care and treatment (695) 695
advanced glycation end-products (694) 694
glucose - metabolism (692) 692
mice, inbred c57bl (691) 691
receptors, immunologic - genetics (691) 691
alzheimers-disease (689) 689
enzyme-linked immunosorbent assay (689) 689
in-vivo (688) 688
oxidative stress - drug effects (679) 679
endproducts (678) 678
insulin-resistance (677) 677
multidisciplinary sciences (672) 672
fluorescence (666) 666
physiology (663) 663
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20431) 20431
Japanese (236) 236
Chinese (211) 211
German (123) 123
French (119) 119
Spanish (75) 75
Korean (66) 66
Italian (60) 60
Russian (53) 53
Polish (48) 48
Czech (34) 34
Portuguese (23) 23
Hungarian (18) 18
Turkish (8) 8
Slovak (7) 7
Romanian (6) 6
Bulgarian (3) 3
Serbian (3) 3
Swedish (3) 3
Ukrainian (3) 3
Norwegian (2) 2
Persian (2) 2
Belarusian (1) 1
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Nutrition, ISSN 0007-1145, 12/2015, Volume 115, Issue 4, pp. 629 - 636
Dietary advanced glycation end products (AGE) formed during heating of food have gained interest as potential nutritional toxins with adverse effects on... 
Advanced glycation end products | Gene for advanced glycation end product receptor 1 | Insulin sensitivity | Gene for receptor for advanced glycation end products | Rats | Gene expression | Body composition | METABOLIC TRANSIT | LIFE-SPAN | ACTIVATION | OXIDANT STRESS | FOODS | GLYCOTOXINS | ENDPRODUCTS AGES | NUTRITION & DIETETICS | RESTRICTED INTAKE | INSULIN-RESISTANCE | MICE | Tumor Necrosis Factor-alpha - metabolism | Up-Regulation | Glycation End Products, Advanced - administration & dosage | Biomarkers - urine | Molecular Weight | Lysine - urine | Diet - adverse effects | Tumor Necrosis Factor-alpha - blood | Tumor Necrosis Factor-alpha - genetics | Milk Proteins - adverse effects | Male | Hexosyltransferases - metabolism | Milk Proteins - administration & dosage | Milk Proteins - chemistry | Proteolysis | Glycation End Products, Advanced - adverse effects | Receptor for Advanced Glycation End Products - genetics | Hexosyltransferases - blood | Receptor for Advanced Glycation End Products - blood | Lysine - analogs & derivatives | Hot Temperature - adverse effects | Receptor for Advanced Glycation End Products - metabolism | Hexosyltransferases - genetics | Biomarkers - blood | Random Allocation | Receptor for Advanced Glycation End Products - agonists | Energy Intake | Rats, Sprague-Dawley | Glycation End Products, Advanced - urine | Renal Elimination | Animals | Glycation End Products, Advanced - chemistry | Toxicity Tests, Subacute | Hexosyltransferases - chemistry | Imidazolines - urine | Imidazoles - urine | Index Medicus
Journal Article
Diabetes, ISSN 0012-1797, 12/2015, Volume 64, Issue 12, pp. 4046 - 4060
Diabetes exacerbates cardiovascular disease, at least in part through suppression of macrophage cholesterol efflux and levels of the cholesterol transporters... 
SIGNALING PATHWAYS | ATHEROSCLEROTIC PLAQUES | GENERAL CONTRASTS | STATIN THERAPY | FOAM-CELL-FORMATION | IN-VIVO | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | PPAR-GAMMA | DEFICIENT MICE | GLYCATION END-PRODUCTS | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Lipoproteins - genetics | Humans | Male | Aorta - metabolism | PPAR gamma - metabolism | ATP Binding Cassette Transporter 1 - metabolism | Lipoproteins - antagonists & inhibitors | Diabetic Angiopathies - pathology | ATP-Binding Cassette Transporters - genetics | Biological Transport | Lipoproteins - metabolism | ATP-Binding Cassette Transporters - metabolism | Plaque, Atherosclerotic - blood | Receptor for Advanced Glycation End Products - genetics | Plaque, Atherosclerotic - pathology | Macrophages - immunology | PPAR gamma - genetics | Receptor for Advanced Glycation End Products - blood | Recombinant Proteins - metabolism | Cell Line | Diabetic Angiopathies - metabolism | Promoter Regions, Genetic | Macrophages - pathology | Plaque, Atherosclerotic - metabolism | Receptor for Advanced Glycation End Products - metabolism | Cells, Cultured | Recombinant Proteins - chemistry | Aorta - immunology | Diabetic Angiopathies - blood | Macrophages - cytology | Plaque, Atherosclerotic - immunology | Receptor for Advanced Glycation End Products - agonists | Cholesterol - metabolism | Mice, Knockout | Aorta - pathology | Macrophages - metabolism | Animals | Diabetic Angiopathies - immunology | Glycation End Products, Advanced - metabolism | Glycation End Products, Advanced - blood | Ligands | ATP Binding Cassette Transporter 1 - genetics | ATP-Binding Cassette Transporters - antagonists & inhibitors | Diabetic acidosis | Care and treatment | Ketoacidosis | Research | Cardiovascular diseases | Macrophages | Risk factors | Cardiovascular disease | Diabetes | Rodents | Cholesterol | Adenosine triphosphatase | Index Medicus | Abridged Index Medicus | Metabolism
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 06/2017, Volume 66, Issue 6, pp. 1683 - 1695
The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) plays a central role in diabetic nephropathy. We screened DNA aptamers... 
VASCULAR COMPLICATIONS | OXIDATIVE STRESS | METABOLIC MEMORY | ENDOTHELIAL-CELLS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | RECEPTOR | RENAL-DISEASE | BIOCHEMICAL BASIS | GLYCATION END-PRODUCTS | Rats, Wistar | Humans | NADPH Oxidases - metabolism | Male | Receptor for Advanced Glycation End Products - antagonists & inhibitors | Albuminuria | Mesangial Cells - drug effects | Kidney - metabolism | NADPH Oxidases - drug effects | Receptor for Advanced Glycation End Products - genetics | Diabetes Mellitus, Experimental - metabolism | Real-Time Polymerase Chain Reaction | Aptamers, Nucleotide - pharmacology | Fibrosis - genetics | Kidney - drug effects | Enzyme-Linked Immunosorbent Assay | Diabetic Nephropathies - metabolism | Receptor for Advanced Glycation End Products - metabolism | Rats | Chemokine CCL2 - genetics | Glycation End Products, Advanced - drug effects | Gene Expression Regulation - drug effects | Animals | Podocytes - drug effects | Glycation End Products, Advanced - metabolism | Mesangial Cells - pathology | Inflammation - genetics | Receptor for Advanced Glycation End Products - drug effects | Oxidative Stress - drug effects | Chemokine CCL2 - drug effects | Oxidative stress | Development and progression | Research | Streptozocin | Diabetic nephropathies | Advanced glycosylation end products | Kidneys | Peptides | Diabetes mellitus | Glycosylation | Inflammation | Macrophages | Experiments | NAD(P)H oxidase | Molecules | Nephropathy | Rodents | Aptamers | Mesangial cells | Extracellular matrix | Diabetes | Kidney diseases | Monocyte chemoattractant protein 1 | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 03/2010, Volume 298, Issue 3, pp. F763 - F770
Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, Forbes JM, Coughlan MT. Disparate... 
Advanced glycation | Advanced glycation end products | Receptor of advanced glycation end products | advanced glycation | PHYSIOLOGY | ALBUMINURIA | PREVENTION | RATS | TERM | GLYCOXIDATION PRODUCTS | advanced glycation end products | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | MICE | DYSFUNCTION | receptor of advanced glycation end products | STRESS | GLYCATION END-PRODUCTS | Diabetes Mellitus, Experimental - drug therapy | Glycation End Products, Advanced - administration & dosage | Diabetic Nephropathies - etiology | Diabetic Nephropathies - drug therapy | Male | Membrane Potential, Mitochondrial - drug effects | Glycolysis - drug effects | Creatinine - metabolism | Kidney - metabolism | Time Factors | Mitochondrial Proteins - metabolism | Adenosine Triphosphate - metabolism | Superoxides - metabolism | Albuminuria - metabolism | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - metabolism | Receptor for Advanced Glycation End Products | Disease Models, Animal | Kidney - drug effects | Albuminuria - etiology | Diabetic Nephropathies - metabolism | Mice, Inbred C57BL | Receptors, Immunologic - deficiency | Mitochondria - metabolism | Mitochondria - drug effects | Disease Progression | Mice, Knockout | Animals | Diet | Ion Channels - metabolism | Albuminuria - drug therapy | Glycation End Products, Advanced - metabolism | Mice | Thiazoles - pharmacology | Uncoupling Protein 2 | Oxidative Stress - drug effects | Receptors, Immunologic - genetics | Diet therapy | Diabetic nephropathies | Development and progression | Genetic aspects | Glycosylation | Research | Gene expression | Observations | Properties | Membranes | Kidneys | Rodents | T cell receptors | Oxidation | Adenosine triphosphatase | Index Medicus
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2015, Volume 764, pp. 554 - 561
Stable microtubules (MTs) is involved the mechanism of diabetic cardiomyopathy (DCM), which is induced by acetylation of α-tubulin. The present study... 
Acetylated α-tubulin | Diabetic cardiomyopathy | Advanced glycation end products | Aminoguanidine | Receptor for advanced glycation end products | SIRT2 | APOPTOSIS | CELLS | CONTRIBUTE | ACETYLATION | SIRTUINS | Acetylated alpha-tubulin | ALPHA-TUBULIN | PHARMACOLOGY & PHARMACY | GLYCATION END-PRODUCTS | Ventricular Function, Left | Diabetes Mellitus, Experimental - enzymology | Diabetes Mellitus, Experimental - genetics | Male | Diabetic Cardiomyopathies - physiopathology | Sirtuin 2 - metabolism | Myocytes, Cardiac - enzymology | Tubulin - metabolism | Transfection | RNA Interference | Echocardiography, Doppler | Acetylation | Protein Stability | Receptor for Advanced Glycation End Products - genetics | Diabetes Mellitus, Experimental - physiopathology | Diabetic Cardiomyopathies - enzymology | Diabetes Mellitus, Type 1 - enzymology | Signal Transduction | Diabetes Mellitus, Type 1 - physiopathology | Receptor for Advanced Glycation End Products - metabolism | Cells, Cultured | Diabetes Mellitus, Type 1 - genetics | Rats, Sprague-Dawley | Diabetic Cardiomyopathies - genetics | Gene Expression Regulation, Enzymologic | Sirtuin 2 - genetics | Animals | Glycation End Products, Advanced - metabolism | Microtubules - enzymology | Protein Binding | Ventricular Pressure | Immunohistochemistry | Heart | Cardiomyopathy | Type 1 diabetes | Analysis | Genetic engineering | Tubulins | Heart diseases | Index Medicus
Journal Article
Matrix Biology, ISSN 0945-053X, 05/2017, Volume 59, pp. 39 - 53
Advanced glycation endproducts (AGEs) are a heterogeneous group of compounds that form via non-enzymatic glycation of proteins throughout our lifespan and at a... 
Non-enzymatic glycation | Extracellular matrix | Advanced glycation endproducts | RAGE | Mass spectrometry | Fibronectin | ATHEROSCLEROTIC LESIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MASS-SPECTROMETRY | CELL BIOLOGY | HUMAN LENS PROTEINS | DIABETES-MELLITUS | GLOMERULAR MESANGIAL CELLS | GROWTH-FACTOR-BETA | NONENZYMATIC GLYCATION | MDIA-INTERACTING PROTEIN | EXTRACELLULAR-MATRIX | END-PRODUCTS | NIH 3T3 Cells | Humans | Extracellular Matrix - metabolism | Integrins - genetics | Receptor for Advanced Glycation End Products - antagonists & inhibitors | Integrins - metabolism | Extracellular Matrix - chemistry | Mesangial Cells - drug effects | Cattle | Fibronectins - agonists | Receptor for Advanced Glycation End Products - genetics | Amino Acid Sequence | Serum Albumin, Bovine - pharmacology | Gene Expression | Pyruvaldehyde - pharmacology | Signal Transduction | Extracellular Matrix - drug effects | Oligopeptides - genetics | Receptor for Advanced Glycation End Products - metabolism | Rats | Antibodies, Neutralizing - pharmacology | Mesangial Cells - metabolism | Oligopeptides - metabolism | Fibronectins - metabolism | Animals | Fibronectins - chemistry | Glycation End Products, Advanced - pharmacology | Models, Biological | Fibrosis | Mesangial Cells - pathology | Fibronectins - genetics | Mice | Pyruvaldehyde - chemistry | Cell Line, Transformed | Fibronectins | Enzymes | Analysis | Chronic diseases | Development and progression | Gene expression | Integrins | Albumin | Bovine serum albumin | Immunoglobulins | Advanced glycosylation end products | Diabetes mellitus | Blocking antibodies | Cystic fibrosis | Mass spectroscopy | Glycosylation | Cell interactions | Proteins | Stimulants | Life span | Mesangial cells | Pyruvaldehyde | Chronic illnesses | Index Medicus | mass spectrometry | non-enzymatic glycation | advanced glycation endproducts | extracellular matrix
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2014, Volume 111, Issue 13, pp. 4940 - 4945
Age-associated dementia and Alzheimer's disease (AD) are currently epidemic. Neither their cause nor connection to the metabolic syndrome (MS) is clear.... 
Anger | Brain | Advanced glycosylation end products | Diet | Neurons | Mice | Cognition | Type 2 diabetes mellitus | Diabetes | Alzheimers disease | Obesity | Insulin resistance | Nutrition | Caloric restriction | Neural | caloric restriction | neural | MULTIDISCIPLINARY SCIENCES | COGNITIVE FUNCTION | DIABETES-MELLITUS | nutrition | INSULIN-RESISTANCE | AMYLOID-BETA | ALZHEIMERS-DISEASE PATIENTS | insulin resistance | POTENTIAL ROLE | obesity | BRAIN | METHYLGLYOXAL | GLYCATION END-PRODUCTS | CALORIE RESTRICTION | Amyloid Precursor Protein Secretases - genetics | Transcription, Genetic - drug effects | Glycation End Products, Advanced - administration & dosage | Pyruvaldehyde - administration & dosage | Humans | Middle Aged | Dementia - physiopathology | Male | Glycation End Products, Advanced - toxicity | PPAR gamma - metabolism | Metabolic Syndrome - blood | Time Factors | Amyloid beta-Peptides - metabolism | Pyruvaldehyde - toxicity | Receptor for Advanced Glycation End Products | Dementia - pathology | Administration, Oral | Membrane Proteins - genetics | Brain - physiopathology | Cognition - drug effects | Brain - drug effects | ADAM Proteins - metabolism | Amyloid Precursor Protein Secretases - metabolism | Brain - pathology | Dementia - blood | Metabolic Syndrome - pathology | Oxidative Stress - drug effects | ADAM Proteins - genetics | Pyruvaldehyde - blood | Memory - drug effects | Sirtuin 1 - metabolism | Pyruvaldehyde - adverse effects | Gliosis - physiopathology | Gliosis - pathology | Nicotinamide Phosphoribosyltransferase - metabolism | Metabolic Syndrome - physiopathology | Female | Glycation End Products, Advanced - adverse effects | Membrane Proteins - metabolism | Insulin - pharmacology | Cytokines - metabolism | Gliosis - metabolism | Mice, Inbred C57BL | ADAM10 Protein | Sirtuin 1 - antagonists & inhibitors | Animals | Aged | Receptors, Immunologic - metabolism | Causes of | Metabolic diseases | Toxins | Health aspects | Dementia | Oxidative stress | Metabolic syndrome | Gene expression | Index Medicus | Biological Sciences
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2005, Volume 20, Issue 9, pp. 1647 - 1658
The impact of AGEs on human MSCs was studied. AGEs inhibited the proliferation of MSCs, induced apoptosis, and prevented cognate differentiation into adipose... 
receptor for advanced glycation end‐products | differentiation | advanced glycation end‐products | proliferation | mesenchymal stem cells | Advanced glycation end-products | Proliferation | Differentiation | Receptor for advanced glycation end-products | Mesenchymal stem cells | DIABETIC COMPLICATIONS | ALDEHYDE DEHYDROGENASE | MAILLARD REACTION | RECEPTOR | advanced glycation end-products | OSTEOBLAST-LIKE CELLS | ENDOCYTIC UPTAKE | ENDOTHELIAL-CELLS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | EXTRACELLULAR-MATRIX | GROWTH-FACTOR EXPRESSION | receptor for advanced glycation end-products | Immunohistochemistry | Bone and Bones - pathology | Chondrocytes - cytology | Cell Proliferation | Reactive Oxygen Species | Calcium - metabolism | Cartilage - pathology | Microscopy, Phase-Contrast | Humans | Adipose Tissue - cytology | Adipocytes - cytology | Stem Cells - cytology | Wound Healing | Microscopy, Immunoelectron | Dose-Response Relationship, Drug | Mesenchymal Stromal Cells - cytology | Time Factors | Cartilage - cytology | Acetaldehyde - pharmacology | Bone and Bones - cytology | Collagen Type II - biosynthesis | Cell Line | Glycation End Products, Advanced - physiology | Phenazines - pharmacology | Enzyme-Linked Immunosorbent Assay | Osteocytes - metabolism | Cell Survival | Adipose Tissue - pathology | Cells, Cultured | Glucose - pharmacology | Lipoprotein Lipase - biosynthesis | Blotting, Western | Bromodeoxyuridine - pharmacology | Cell Differentiation - drug effects | Glycation End Products, Advanced - metabolism | Glyceraldehyde - pharmacology | Microscopy, Fluorescence | Acetaldehyde - analogs & derivatives | Apoptosis | Index Medicus
Journal Article